Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Idai Stock Analysis T Stamp Inc. Posts 6.64 Percent Daily Gain At 2.57 Per Share Level 20260401 1 Nams Stock Analysis Newamsterdam Pharma 0.55 Pct Daily Gain 32.99 Price Outlook 20260403 1 Kevin Warsh Confirmed as Federal Reserve Chair in Landmark Vote MMTec Inc MTC Down 891 How Low Could It Go 20260515 Senseonics Holdings SENS Q1 2026 Earnings Miss EPS 071 vs 069 Expected Canadian Biotech Sector Update Key Opportunities in 2026 Is ApexTreasury APXT Undervalued at 1000 20260514 Telecom TEO Stock Analysis Falls 443 Watching 1127 20260515 Mizuho MFG Down 386 How Low Could It Go 20260518 Is Primerica PRI Still a Buy After 205 Rally 20260518 111 Inc YI Q3 2024 Earnings Preview What to Expect Infobip Again Named a Leader in Gartner Magic Quadrant for CPaaS Tops in Completeness of Vision Why Galaxy GLXG Just Surged 100 Key Levels Ahead 20260520 Blockchaincom Submits IPO Filing in the United States Morgan Stanley Lowers Edison International Price Target on April Utility Review New York Nears Finalization of Luxury Second Home Tax Set for July Market Speculates on Timeline for Potential Shift Away from Quarterly Earnings Reports Wall Street Advances Dow Jones Reaches Record High on Middle East Optimism EU Industry Chief Warns Against Overreliance on SingleCountry Supply Amid China Tensions OCSL Q1 2026 Earnings EPS Surpasses Estimates as Portfolio Remains Resilient SYF Q1 2026 Earnings Earnings Beat Estimates Amid Stable Credit Trends BTG Q1 2026 Earnings EPS Surges Past Estimates by 43 Yet Stock Declines Norfolk Southern Q1 2026 Earnings Rail Operator Beats EPS Estimates Amid Operational Resilience OUST Q1 2026 Earnings EPS Beat Lifts Lidar Makers Stock YXTCOM Group Holding Limited YXT Edges Higher on Modest Buying Testing Key Resistance Intercure Ltd INCR Rallies 48 Testing Key Resistance at 097 Saratoga Investment Corp SAR Holds Steady at 2223 Amid Tight Trading Range Arbutus Biopharma ABUS Dips 2 Testing Key Support Levels Amid Modest Trading Volume